Age: 55.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Influenza like illness, Injection site vesicles, Wrong product administered
Clinical narrative: After Shingrix vaccination, she had flu-like symptoms; After Shingrix vaccination, she developed a shingles-like blister at the site of the Aimovig injection; she has not yet received her second dose of Shingrix; mistakenly gave Shingrix (first dose) rather than the whooping cough vaccine; This non-serious case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis and erenumab (Aimovig) for product used for unknown indication.   Previously administered products included Zostavax (received on January 2019) and Aimovig (received previously on an unknown date).   On 14-NOV-2021, the patient received the 1st dose of Shingrix (intramuscular, unknown deltoid) .5 ml. On an unknown date, the patient received the 2nd dose of Shingrix. On 14-NOV-2021, the patient started Aimovig (unknown thigh). On 14-NOV-2021, an unknown time after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced wrong vaccine administered (Verbatim: mistakenly gave Shingrix (first dose) rather than the whooping cough vaccine). On an unknown date, the patient experienced influenza-like symptoms (Verbatim: After Shingrix vaccination, she had flu-like symptoms), blister (Verbatim: After Shingrix vaccination, she developed a shingles-like blister at the site of the Aimovig injection) and incomplete course of vaccination (Verbatim: she has not yet received her second dose of Shingrix). The action taken with Aimovig was unknown. The outcome of the influenza-like symptoms and blister were resolved and the outcome of the wrong vaccine administered and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix. The reporter considered the blister to be possibly related to Shingrix.     It was unknown if the company considered the influenza-like symptoms to be related to Shingrix. The company considered the blister to be possibly related to Shingrix.   Additional Information: GSK receipt date: 02-JAN-2024 The patient self-reported this case.  Her pharmacy mistakenly gave her Shingrix (first dose) rather than the whooping cough vaccine, which led to wrong vaccine administered. She had also received her usual Aimovig injection in thigh on 14th November 2021.  After Shingrix vaccination, she had flu-like symptoms that was resolved.  After Shingrix vaccination, she developed a shingles-like blister at the site of the Aimovig injection.  She had never previously (nor since) had an Aimovig injection-site reaction.  She believed Shingrix caused the Aimovig injection-site blister. Vaers details was reported for 1st dose of Shingrix. It was unknown if the reporter considered the adverse events related to Aimovig. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter consented to follow up with patient/reporter and might contact her neurologist.